Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Cash from Operations (2024 - 2025)

Historic Cash from Operations for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to -$17.4 million.

  • Connect Biopharma Holdings' Cash from Operations fell 3382.03% to -$17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.3 million, marking a year-over-year change of. This contributed to the annual value of -$23.6 million for FY2024, which is 5054.15% up from last year.
  • Latest data reveals that Connect Biopharma Holdings reported Cash from Operations of -$17.4 million as of Q3 2025, which was down 3382.03% from -$12.6 million recorded in Q2 2025.
  • In the past 5 years, Connect Biopharma Holdings' Cash from Operations ranged from a high of -$591000.0 in Q1 2024 and a low of -$17.4 million during Q3 2025